SCHEMBL3023737

SCHEMBL3023737

CC(C)CNC(=O)c1cccc(-c2ccc(C(N)=O)cc2)c1O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.55
F3 P13726 4/20 0.50
KMT2A Q03164 2/20 0.48
GAA P10253 1/20 0.48
HSD17B10 Q99714 1/20 0.48
PLAU P00749 1/20 0.47
PLAT P00750 1/20 0.47
PRSS1 P07477 2/20 0.43
PRSS2 P07478 2/20 0.43
PRSS3 P35030 2/20 0.43
F2 P00734 2/20 0.43
F10 P00742 2/20 0.43
F7 P08709 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
CTSS P25774 1/20 0.42
CTSK P43235 1/20 0.42
MAPK14 Q16539 1/20 0.41
KDM4E B2RXH2 2/20 0.41
HPGD P15428 3/20 0.41
MKNK1 Q9BUB5 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3453931 0.79 HNF4A (0.53) POLBHSD17B10PLAUPLATKDM4E
SCHEMBL3025996 0.76 RAB9A (0.57) KMT2AGAASMN1; SMN2HPGD
SCHEMBL6273049 0.76 GAA (0.66) POLBF3KMT2AGAAHSD17B10
SCHEMBL12260804 0.75 POLB (0.55) POLBKMT2AGAAHSD17B10SMN1; SMN2
SCHEMBL3025881 0.75 RAB9A (0.61) KMT2AMAPK14KDM4EHPGD
SCHEMBL3037017 0.74 HTT (0.64) POLBKMT2AGAASMN1; SMN2KDM4E
SCHEMBL5482854 0.74 GAA (0.61) F3KMT2AGAAHSD17B10PLAU
SCHEMBL3038374 0.73 TAS1R3 (0.57) KMT2AGAAPLAUPLATSMN1; SMN2
SCHEMBL3018085 0.73 PLAU (0.61) POLBKMT2AGAAPLAUPLAT
SCHEMBL3035150 0.73 MEN1 (0.54) KMT2APLAUPLATPRSS1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100216796-A1 N-HYDROXY-NAPHTHALENE DICARBOXAMIDE AND N-HYDROXY-BIPHENYL-DICARBOXAMIDE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS KATTAR SOLOMON 2010-08-26 US claimed
US-20100216796-A1 N-HYDROXY-NAPHTHALENE DICARBOXAMIDE AND N-HYDROXY-BIPHENYL-DICARBOXAMIDE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS KATTAR SOLOMON 2010-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100216796-A1 N-HYDROXY-NAPHTHALENE DICARBOXAMIDE AND N-HYDROXY-BIPHENYL-DICARBOXAMIDE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS BRDT, AADAC, ACIN1 POLB 3269/4885F3 1725/4885KMT2A 32/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.